Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New EU study aims to boost resilience in millions of unpaid caregivers

NCT ID NCT07708649

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests digital education and peer-support programs designed to improve resilience and mental wellbeing in informal carers and long-term care workers. Researchers will roll out these programs in five European countries and measure their effects on mental health and care partnerships. The goal is to identify practices that can be adopted across different healthcare systems to better support those who care for others.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital educational program and peer-to-peer support program
What this could lead to
If successful, this could point toward scalable ways to improve mental wellbeing and resilience among the millions of unpaid caregivers and long-term care workers across Europe.
What could go wrong
This is an implementation study, not a controlled drug trial, so results may vary by local context and may not be generalizable. The interventions are still being developed, and the study does not test a single standardized treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 450 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for recruiting participants will be... For informal caregivers: o currently providing - or having provided within the last 6 months - unpaid care or support to a family member, partner, or friend receiving long-term care services; For long-term care workers: * employed in a long-term care setting at one of the participating research sites; * directly involved in care provision or implementation of the new practices under study; For care recipients: * currently receiving care from long-term care workers and/or informal caregivers; * requiring support with everyday personal care and/or more complex daily tasks due to ageing, chronic illness, disability or frailty; * living in the community or in a long-term care setting included in the study; \- for other stakeholders: * involved directly or indirectly in the planning, management, or implementation of the newly adopted practices at the research site; For all participants: * aged 18 years or older; * able to provide informed consent; * sufficient proficiency in the local language to complete the questionnaire and/or participate in an interview; The exclusion criteria for recruiting participants will be... * having a (permanent or temporary) psychiatric disorder or mental illness which makes the person unable to understand instructions and participate in the study activities; * experiencing circumstances that would make participation unduly burdensome (e.g., acute stress or illness); * providing care for fewer than the minimum number of hours required for inclusion; the threshold will be defined per country in a context-sensitive way, reflecting national differences and the characteristics of the implemented practices and their target populations; * only being involved in the provision or receiving of short-term or acute care (i.e., not long-term care);

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental wellbeing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites in 5 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hochschule Zittau/Görlitz

    Zittau, Germany

  • INRCA

    Ancona, Italy

  • Linneaus University

    Kalmar, Sweden

  • University of Ljubljana

    Ljubljana, Slovenia

  • Vrije Universiteit Amsterdam

    Amsterdam, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.